Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,

Participants with metabolic syndrome who received 1,700 mg metformin daily with or without a Mediterranean diet intervention had reduced incidence of diabetes compared with placebo, according to findings published in Diabetes Care.

The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies show it lowers kidney-related complications by 24 per cent. This offers new hope for patients,

On average, the burden of sugar-sweetened beverage intake was higher among men than women, as well as among younger adults, higher-educated adults and those in urban areas.

Developing regions such as Sub-Saharan Africa, Latin America, and the Caribbean showed particularly alarming numbers

According to a review of hospital-based cross-sectional studies, almost half the type 2 diabetes population is micronutrient deficient.

A recent study suggests that type 2 diabetes can be reversed through a combination of calorie reduction, physical activity, and the diabetes drug dapagliflozin, offering new hope for patients.

Micronutrient deficiencies commonly occur in individuals with type 2 diabetes, according to a systematic review and meta-analysis published in BMJ Nutrition, Prevention and Health.Women had the greatest risk for these deficiencies,

The researcher assessed data from 184 countries to estimate global cases of Type 2 diabetes and cardiovascular disease due to sugar0sweetened beverage intake. In addition to cases of Type 2 diabetes,

Nearly half of people with type 2 diabetes suffer from  low levels of essential nutrients, according to a new study.Researchers found as many as 45% of typ

A popular diabetes drug just got a major new approval—and it could be a game-changer for millions of Americans at risk for kidney failure.